OBJECTIVE: To study the implementation of a patient education program on relapses and relapse therapy into routine care. METHODS: 31 health care professionals took part in a one day train-the-trainer program (TTTP) and subsequently 261 persons with MS (pwMS) took part in the education program. Evaluation was carried out in trainers and pwMS. RESULTS: Participants (health professionals) in the TTTP understood the program's main goals and reported that the TTTP enabled them to successfully perform the program. The majority of participants in the program (pwMS) understood the core messages. Also, they showed increased risk knowledge and increased decision autonomy preferences. Treatment decisions were reported as autonomous or as "informed choice" in 49%, and as "shared decisions" by 45%. Overall, effects were less marked compared to the results of the underlying randomized-controlled trial. CONCLUSION: PwMS! appreciate evidence-based information about relapse management and view the unbiased presentation of scientific uncertainty as a chance for decision autonomy. PRACTICE IMPLICATIONS: The implementation study confirms the program's transferability into clinical practice.
OBJECTIVE: To study the implementation of a patient education program on relapses and relapse therapy into routine care. METHODS: 31 health care professionals took part in a one day train-the-trainer program (TTTP) and subsequently 261 persons with MS (pwMS) took part in the education program. Evaluation was carried out in trainers and pwMS. RESULTS:Participants (health professionals) in the TTTP understood the program's main goals and reported that the TTTP enabled them to successfully perform the program. The majority of participants in the program (pwMS) understood the core messages. Also, they showed increased risk knowledge and increased decision autonomy preferences. Treatment decisions were reported as autonomous or as "informed choice" in 49%, and as "shared decisions" by 45%. Overall, effects were less marked compared to the results of the underlying randomized-controlled trial. CONCLUSION: PwMS! appreciate evidence-based information about relapse management and view the unbiased presentation of scientific uncertainty as a chance for decision autonomy. PRACTICE IMPLICATIONS: The implementation study confirms the program's transferability into clinical practice.
Authors: Maria Janina Wendebourg; Lena Katharina Feddersen; Stephanie Lau; Sascha Köpke; Rona Moss-Morris; Christoph Heesen; Jana Pöttgen Journal: Int J MS Care Date: 2016 May-Jun
Authors: Peter Rieckmann; Alexey Boyko; Diego Centonze; Alasdair Coles; Irina Elovaara; Eva Havrdová; Otto Hommes; Jacques Lelorier; Sarah A Morrow; Celia Oreja-Guevara; Nick Rijke; Sven Schippling Journal: J Neurol Date: 2012-08-31 Impact factor: 4.849
Authors: Anne Christin Rahn; Lisa Wenzel; Andrea Icks; Alexander Stahmann; Jutta Scheiderbauer; Kristina Grentzenberg; Markus Vomhof; Joseph Montalbo; Tim Friede; Christoph Heesen; Sascha Köpke Journal: Trials Date: 2021-02-14 Impact factor: 2.279
Authors: Lisa Wenzel; Christoph Heesen; Julia Peper; Kristina Grentzenberg; Edeltraud Faßhauer; Jutta Scheiderbauer; Frithjof Thale; Björn Meyer; Sascha Köpke; Anne Christin Rahn Journal: Front Neurol Date: 2022-09-23 Impact factor: 4.086